(NASDAQ: AFFX) today announced the expansion of its license agreement with Siemens Healthcare Diagnostics for the company’s branched DNA (bDNA) technology whereby Affymetrix is the exclusive licensee ...
SANTA CLARA, Calif. & SAN DIEGO--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ:AFFX) and Reveal Biosciences LLC, an advanced tissue technologies company, today announced a partnership agreement through ...
Partnership will expand use of assay into pathology and cancer research markets. Affymetrix and the Massachusetts General Hospital (MGH) inked a collaboration and licensing agreement to co-develop ...
Technology combines ScreenCell’s isolation devices with Affymetrix’ QuantiGene ViewRNA assay. Affymetrix signed a worldwide distribution agreement for ScreenCell’s isolation devices and dilution ...
Affymetrix, Inc. and ScreenCell have announced the signing of a worldwide distribution agreement for ScreenCell’s isolation devices and dilution buffers, designed for the collection of Circulating ...
Affymetrix Inc. and Reveal Biosciences LLC, an advanced tissue technologies company, announced a partnership agreement through which Reveal will use Affymetrix ViewRNA ISH products for tissue samples ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results